Recruiting
Phase 1

Study of SFA002 in Patients With Mild to Moderate Psoriasis Plaques

Sponsor:

SFA Therapeutics

Code:

NCT05642182

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Drug (SFA002) Vitamin D, Magnesium

Drug (SFA002) Vitamin D, Magnesium and Propionate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information